{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:52:01Z","timestamp":1761699121912,"version":"build-2065373602"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011052","name":"Federal State Budget Scientific Institution Research Institute - Republican Research and Consulting Center of Expertise","doi-asserted-by":"publisher","award":["202040341"],"award-info":[{"award-number":["202040341"]}],"id":[{"id":"10.13039\/501100011052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12010-025-05297-y","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:37:15Z","timestamp":1750646235000},"page":"5608-5628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Associations Between Peripheral Blood Gene Expression and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Using an Improved Joint Multi-Task Sparse Canonical Correlation Analysis Algorithm"],"prefix":"10.1007","volume":"197","author":[{"given":"Qianqian","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"5297_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.dadm.2019.05.007","volume":"11","author":"SL Risacher","year":"2019","unstructured":"Risacher, S. L., Fandos, N., Romero, J., Sherriff, I., Pesini, P., Saykin, A. J., & Apostolova, L. G. (2019). Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition. Alzheimer\u2019s & dementia (Amsterdam, Netherlands), 11, 510\u2013519.","journal-title":"Alzheimer's & dementia (Amsterdam, Netherlands)"},{"key":"5297_CR2","doi-asserted-by":"crossref","unstructured":"L, D. U., Liu, F., Liu, K., Yao, X., Risacher, S. L., Han, J., Guo, L., Saykin, A. J., Shen, L. (2020) Identifying diagnosis-specific genotype-phenotype associations via joint multitask sparse canonical correlation analysis and classification, Bioinformatics (Oxford, England) 36(Suppl_1) i371-i379.","DOI":"10.1093\/bioinformatics\/btaa434"},{"key":"5297_CR3","doi-asserted-by":"publisher","unstructured":"Daschil, N., Obermair, G. J., Flucher, B. E., Stefanova, N., Hutter-Paier, B., Windisch, M., Humpel, C., & Marksteiner, J. (2013). CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-\u03b2 plaques in an Alzheimer's disease mouse model. Journal of Alzheimer's disease, 37(2), 439\u2013451. https:\/\/doi.org\/10.3233\/JAD-130560","DOI":"10.3233\/JAD-130560"},{"key":"5297_CR4","doi-asserted-by":"publisher","unstructured":"Arfaei, R., Mikaeili, N., Daj, F., Boroumand, A., Kheyri, A., Yaraghi, P., Shirzad, Z., Keshavarz, M., Hassanshahi, G., Jafarzadeh, A., Shahrokhi, V. M., & Khorramdelazad, H. (2024). Decoding the role of the CCL2\/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open. International Immunopharmacology, 135, 112328. https:\/\/doi.org\/10.1016\/j.intimp.2024.112328","DOI":"10.1016\/j.intimp.2024.112328"},{"key":"5297_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2021.02.001","volume":"102","author":"C Giovagnoni","year":"2021","unstructured":"Giovagnoni, C., Ali, M., Eijssen, L. M. T., Maes, R., Choe, K., Mulder, M., Kleinjans, J., Del Sol, A., Glaab, E., Mastroeni, D., Delvaux, E., Coleman, P., Losen, M., Pishva, E., Martinez-Martinez, P., & van den Hove, D. L. A. (2021). Altered sphingolipid function in Alzheimer\u2019s disease; a gene regulatory network approach. Neurobiology of aging, 102, 178\u2013187.","journal-title":"Neurobiology of aging"},{"issue":"2","key":"5297_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7150\/ijbs.26703","volume":"15","author":"A Jorda","year":"2019","unstructured":"Jorda, A., Cauli, O., Santonja, J. M., Aldasoro, M., Aldasoro, C., Obrador, E., Vila, J. M., Mauricio, M. D., Iradi, A., Guerra-Ojeda, S., Marchio, P., & Valles, S. L. (2019). Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer\u2019s Disease. International journal of biological sciences, 15(2), 453\u2013463.","journal-title":"International journal of biological sciences"},{"issue":"4","key":"5297_CR7","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3233\/JAD-170205","volume":"66","author":"GS Leandro","year":"2018","unstructured":"Leandro, G. S., Evangelista, A. F., Lobo, R. R., Xavier, D. J., Moriguti, J. C., & Sakamoto-Hojo, E. T. (2018). Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer\u2019s Disease Patients. Journal of Alzheimer\u2019s disease\u202f: JAD, 66(4), 1483\u20131495.","journal-title":"Journal of Alzheimer's disease : JAD"},{"issue":"8","key":"5297_CR8","first-page":"824","volume":"10","author":"X Dai","year":"2021","unstructured":"Dai, X., Karol, M. D., Hitron, M., Hard, M. L., Goulet, M. T., McLaughlin, C. F., & Brantley, S. J. (2021). Napabucasin Drug-Drug Interaction Potential. Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers, Clinical pharmacology in drug development, 10(8), 824\u2013839.","journal-title":"Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers, Clinical pharmacology in drug development"},{"issue":"1","key":"5297_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12974-020-02036-4","volume":"17","author":"JD Cherry","year":"2020","unstructured":"Cherry, J. D., Meng, G., Daley, S., Xia, W., Svirsky, S., Alvarez, V. E., Nicks, R., Pothast, M., Kelley, H., Huber, B., Tripodis, Y., Alosco, M. L., Mez, J., McKee, A. C., & Stein, T. D. (2020). CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy. Journal of neuroinflammation, 17(1), 370.","journal-title":"Journal of neuroinflammation"},{"issue":"11","key":"5297_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1089\/neu.2017.5368","volume":"35","author":"EJ Mufson","year":"2018","unstructured":"Mufson, E. J., He, B., Ginsberg, S. D., Carper, B. A., Bieler, G. S., Crawford, F., Alvarez, V. E., Huber, B. R., Stein, T. D., McKee, A. C., & Perez, S. E. (2018). Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study. Journal of neurotrauma, 35(11), 1260\u20131271.","journal-title":"Journal of neurotrauma"},{"key":"5297_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3389\/fimmu.2020.00997","volume":"11","author":"A Joly-Amado","year":"2020","unstructured":"Joly-Amado, A., Hunter, J., Quadri, Z., Zamudio, F., Rocha-Rangel, P. V., Chan, D., Kesarwani, A., Nash, K., Lee, D. C., Morgan, D., Gordon, M. N., & Selenica, M. B. (2020). CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy. Frontiers in immunology, 11, 997.","journal-title":"Frontiers in immunology"},{"key":"5297_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fneur.2018.00549","volume":"9","author":"JR Guedes","year":"2018","unstructured":"Guedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018). Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer\u2019s Disease-Associated Amyloid-\u03b2 and Tau Pathologies. Frontiers in neurology, 9, 549.","journal-title":"Frontiers in neurology"},{"issue":"2","key":"5297_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ajpath.2011.10.027","volume":"180","author":"SE Perez","year":"2012","unstructured":"Perez, S. E., Getova, D. P., He, B., Counts, S. E., Geula, C., Desire, L., Coutadeur, S., Peillon, H., Ginsberg, S. D., & Mufson, E. J. (2012). Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer\u2019s disease. The American journal of pathology, 180(2), 526\u2013540.","journal-title":"The American journal of pathology"},{"issue":"1","key":"5297_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","volume":"76","author":"S Kim","year":"2011","unstructured":"Kim, S., Swaminathan, S., Shen, L., Risacher, S. L., Nho, K., Foroud, T., Shaw, L. M., Trojanowski, J. Q., Potkin, S. G., Huentelman, M. J., Craig, D. W., DeChairo, B. M., Aisen, P. S., Petersen, R. C., Weiner, M. W., & Saykin, A. J. (2011). Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology, 76(1), 69\u201379.","journal-title":"Neurology"},{"key":"5297_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.575953","volume":"11","author":"AG Bryant","year":"2020","unstructured":"Bryant, A. G., Hu, M., Carlyle, B. C., Arnold, S. E., Frosch, M. P., Das, S., Hyman, B. T., & Bennett, R. E. (2020). Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer\u2019s Disease. Frontiers in neurology, 11, Article 575953.","journal-title":"Frontiers in neurology"},{"issue":"7","key":"5297_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006197","volume":"4","author":"T Kiyota","year":"2009","unstructured":"Kiyota, T., Yamamoto, M., Xiong, H., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009). CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. PLoS ONE, 4(7), Article e6197.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"5297_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000357383","volume":"93","author":"N Daschil","year":"2014","unstructured":"Daschil, N., Geisler, S., Obermair, G. J., & Humpel, C. (2014). Short- and long-term treatment of mouse cortical primary astrocytes with \u03b2-amyloid differentially regulates the mRNA expression of L-type calcium channels. Pharmacology, 93(1\u20132), 24\u201331.","journal-title":"Pharmacology"},{"issue":"17","key":"5297_CR18","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","volume":"29","author":"H Xiong","year":"2009","unstructured":"Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D., Lue, L. F., Stanimirovic, D., & Zhang, W. (2009). ABCG2 is upregulated in Alzheimer\u2019s brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1\u201340) peptides. The Journal of neuroscience\u202f: The official journal of the Society for Neuroscience, 29(17), 5463\u20135475.","journal-title":"The Journal of neuroscience : The official journal of the Society for Neuroscience"},{"issue":"3","key":"5297_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neures.2006.07.009","volume":"56","author":"S Ito","year":"2006","unstructured":"Ito, S., Sawada, M., Haneda, M., Ishida, Y., & Isobe, K. (2006). Amyloid-beta peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K\/Akt and\/or ERK pathway. Neuroscience research, 56(3), 294\u2013299.","journal-title":"Neuroscience research"},{"issue":"1","key":"5297_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-018-0296-y","volume":"13","author":"H Wang","year":"2018","unstructured":"Wang, H., Li, Y., Ryder, J. W., Hole, J. T., Ebert, P. J., Airey, D. C., Qian, H. R., Logsdon, B., Fisher, A., Ahmed, Z., Murray, T. K., Cavallini, A., Bose, S., Eastwood, B. J., Collier, D. A., Dage, J. L., Miller, B. B., Merchant, K. M., O\u2019Neill, M. J., & Demattos, R. B. (2018). Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model. Molecular neurodegeneration, 13(1), 65.","journal-title":"Molecular neurodegeneration"},{"key":"5297_CR21","doi-asserted-by":"publisher","first-page":"7619255","DOI":"10.1155\/2022\/7619255","volume":"2022","author":"L Liu","year":"2022","unstructured":"Liu, L., Bai, J., Liu, F., Xu, Y., Zhao, M., Zhao, C., & Zhou, Z. (2022). Cross-Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer\u2019s Disease and Huntington\u2019s Disease. Oxidative medicine and cellular longevity, 2022, 7619255.","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"2","key":"5297_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-210480","volume":"85","author":"M Neshan","year":"2022","unstructured":"Neshan, M., Malakouti, S. K., Kamalzadeh, L., Makvand, M., Campbell, A., & Ahangari, G. (2022). Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer\u2019s Disease. Journal of Alzheimer\u2019s disease\u202f: JAD, 85(2), 645\u2013665.","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"key":"5297_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","volume":"11","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020). Interleukin-17 in Chronic Inflammatory Neurological Diseases. Frontiers in immunology, 11, 947.","journal-title":"Frontiers in immunology"},{"issue":"8","key":"5297_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/jnr.24004","volume":"95","author":"X Kong","year":"2017","unstructured":"Kong, X., Yuan, Z., & Cheng, J. (2017). The function of NOD-like receptors in central nervous system diseases. Journal of neuroscience research, 95(8), 1565\u20131573.","journal-title":"Journal of neuroscience research"},{"key":"5297_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135279","volume":"736","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Dai, Y., Li, Q., Chen, C., Chen, H., Song, Y., Hua, F., & Zhang, Z. (2020). Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia. Neuroscience letters, 736, Article 135279.","journal-title":"Neuroscience letters"},{"issue":"1","key":"5297_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40478-021-01264-w","volume":"9","author":"A Jayaraman","year":"2021","unstructured":"Jayaraman, A., Htike, T. T., James, R., Picon, C., & Reynolds, R. (2021). TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer\u2019s disease hippocampus. Acta neuropathologica communications, 9(1), 159.","journal-title":"Acta neuropathologica communications"},{"issue":"4","key":"5297_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.bbadis.2006.11.007","volume":"1772","author":"J Caltagarone","year":"2007","unstructured":"Caltagarone, J., Jing, Z., & Bowser, R. (2007). Focal adhesions regulate Abeta signaling and cell death in Alzheimer\u2019s disease. Biochimica et biophysica acta, 1772(4), 438\u2013445.","journal-title":"Biochimica et biophysica acta"},{"issue":"9","key":"5297_CR28","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1111\/ejn.15569","volume":"56","author":"R Kumar","year":"2022","unstructured":"Kumar, R., Tiwari, V., & Dey, S. (2022). Role of proline-rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer\u2019s disease. The European journal of neuroscience, 56(9), 5442\u20135452.","journal-title":"The European journal of neuroscience"},{"issue":"7","key":"5297_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/ncb1007","volume":"5","author":"M Maillet","year":"2003","unstructured":"Maillet, M., Robert, S. J., Cacquevel, M., Gastineau, M., Vivien, D., Bertoglio, J., Zugaza, J. L., Fischmeister, R., & Lezoualc\u2019h, F. (2003). Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nature cell biology, 5(7), 633\u2013639.","journal-title":"Nature cell biology"},{"issue":"1","key":"5297_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-018-0283-3","volume":"13","author":"M Dumbacher","year":"2018","unstructured":"Dumbacher, M., Van Dooren, T., Princen, K., De Witte, K., Farinelli, M., Lievens, S., Tavernier, J., Dehaen, W., Wera, S., Winderickx, J., Allasia, S., Kilonda, A., Spieser, S., Marchand, A., Chaltin, P., Hoogenraad, C. C., & Griffioen, G. (2018). Modifying Rap1-signalling by targeting Pde6\u03b4 is neuroprotective in models of Alzheimer\u2019s disease. Molecular neurodegeneration, 13(1), 50.","journal-title":"Molecular neurodegeneration"},{"issue":"4","key":"5297_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","volume":"1802","author":"EK Kim","year":"2010","unstructured":"Kim, E. K., & Choi, E. J. (2010). Pathological roles of MAPK signaling pathways in human diseases. Biochimica et biophysica acta, 1802(4), 396\u2013405.","journal-title":"Biochimica et biophysica acta"},{"issue":"3","key":"5297_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00249-007-0244-1","volume":"37","author":"G Filiz","year":"2008","unstructured":"Filiz, G., Price, K. A., Caragounis, A., Du, T., Crouch, P. J., & White, A. R. (2008). The role of metals in modulating metalloprotease activity in the AD brain. European biophysics journal\u202f: EBJ, 37(3), 315\u2013321.","journal-title":"European biophysics journal : EBJ"},{"issue":"4","key":"5297_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-013-1242-2","volume":"127","author":"B Brawek","year":"2014","unstructured":"Brawek, B., Schwendele, B., Riester, K., Kohsaka, S., Lerdkrai, C., Liang, Y., & Garaschuk, O. (2014). Impairment of in vivo calcium signaling in amyloid plaque-associated microglia. Acta neuropathologica, 127(4), 495\u2013505.","journal-title":"Acta neuropathologica"},{"issue":"7","key":"5297_CR34","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","volume":"37","author":"H Zheng","year":"2017","unstructured":"Zheng, H., Jia, L., Liu, C. C., Rong, Z., Zhong, L., Yang, L., Chen, X. F., Fryer, J. D., Wang, X., Zhang, Y. W., Xu, H., & Bu, G. (2017). TREM2 Promotes Microglial Survival by Activating Wnt\/\u03b2-Catenin Pathway, The Journal of neuroscience\u202f: The official journal of the Society for. Neuroscience, 37(7), 1772\u20131784.","journal-title":"Neuroscience"},{"key":"5297_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.lfs.2017.10.033","volume":"193","author":"A Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e, A., Lecarpentier, Y., Guillevin, R., & Vall\u00e9e, J. N. (2018). Reprogramming energetic metabolism in Alzheimer\u2019s disease. Life sciences, 193, 141\u2013152.","journal-title":"Life sciences"},{"key":"5297_CR36","first-page":"81","volume":"7","author":"AM L\u00fcchtenborg","year":"2014","unstructured":"L\u00fcchtenborg, A. M., & Katanaev, V. L. (2014). Lack of evidence of the interaction of the A\u03b2 peptide with the Wnt signaling cascade in Drosophila models of Alzheimer\u2019s disease. Molecular brain, 7, 81.","journal-title":"Molecular brain"},{"issue":"7","key":"5297_CR37","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004). Incipient Alzheimer\u2019s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proceedings of the National Academy of Sciences of the United States of America, 101(7), 2173\u20132178.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"5297_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10517-018-4238-z","volume":"165","author":"MA Mukhamedyarov","year":"2018","unstructured":"Mukhamedyarov, M. A., Grigor\u2019ev, P. N., Ushanova, E. A., Zefirov, T. L., Leushina, A. V., & Zefirov, A. L. (2018). Dysfunction of Neuromuscular Synapses in the Genetic Model of Alzheimer\u2019s Disease. Bulletin of experimental biology and medicine, 165(5), 669\u2013673.","journal-title":"Bulletin of experimental biology and medicine"},{"issue":"9","key":"5297_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2174\/1871530320666200131110744","volume":"20","author":"A Jorda","year":"2020","unstructured":"Jorda, A., Campos-Campos, J., Iradi, A., Aldasoro, M., Aldasoro, C., Vila, J. M., & Valles, S. L. (2020). The Role of Chemokines in Alzheimer\u2019s Disease. Endocrine, metabolic & immune disorders drug targets, 20(9), 1383\u20131390.","journal-title":"Endocrine, metabolic & immune disorders drug targets"},{"key":"5297_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuroscience.2020.09.024","volume":"448","author":"R Das","year":"2020","unstructured":"Das, R., & Chinnathambi, S. (2020). Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer\u2019s Disease. Neuroscience, 448, 325\u2013336.","journal-title":"Neuroscience"},{"issue":"2","key":"5297_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JAD-121813","volume":"34","author":"GD Femminella","year":"2013","unstructured":"Femminella, G. D., Rengo, G., Pagano, G., de Lucia, C., Komici, K., Parisi, V., Cannavo, A., Liccardo, D., Vigorito, C., Filardi, P. P., Ferrara, N., & Leosco, D. (2013). \u03b2-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer\u2019s disease: A new paradigm for prognosis and therapy? Journal of Alzheimer\u2019s disease\u202f: JAD, 34(2), 341\u2013347.","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"key":"5297_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuropharm.2017.03.030","volume":"119","author":"H Zhu","year":"2017","unstructured":"Zhu, H., Xue, X., Wang, E., Wallack, M., Na, H., Hooker, J. M., Kowall, N., Tao, Q., Stein, T. D., Wolozin, B., & Qiu, W. Q. (2017). Amylin receptor ligands reduce the pathological cascade of Alzheimer\u2019s disease. Neuropharmacology, 119, 170\u2013181.","journal-title":"Neuropharmacology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05297-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05297-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05297-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:02:03Z","timestamp":1761685323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05297-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["5297"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05297-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"21 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}